GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Inventory-to-Revenue

Implantica AG (OSTO:IMP A SDB) Inventory-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Implantica AG's Average Total Inventories for the quarter that ended in . 20 was kr0.00 Mil. Implantica AG's Revenue for the six months ended in . 20 was kr0.00 Mil.

Implantica AG's Inventory-to-Revenue for the quarter that ended in . 20 stayed the same from . 20 (0.00) to . 20 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Implantica AG Inventory-to-Revenue Historical Data

The historical data trend for Implantica AG's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Inventory-to-Revenue Chart

Implantica AG Annual Data
Trend
Inventory-to-Revenue

Implantica AG Semi-Annual Data
Inventory-to-Revenue

Competitive Comparison of Implantica AG's Inventory-to-Revenue

For the Medical Devices subindustry, Implantica AG's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Implantica AG's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Implantica AG's Inventory-to-Revenue falls into.


;
;

Implantica AG Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Implantica AG's Inventory-to-Revenue for the fiscal year that ended in . 20 is calculated as

Inventory-to-Revenue (A: . 20 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: . 20 ) + Total Inventories (A: . 20 )) / count ) / Revenue (A: . 20 )
=( ( + ) / 1 ) /
=0 /
=N/A

Implantica AG's Inventory-to-Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue (Q: . 20 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: . 20 ) + Total Inventories (Q: . 20 )) / count ) / Revenue (Q: . 20 )
=( ( + ) / 1 ) /
=0 /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Implantica AG  (OSTO:IMP A SDB) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Implantica AG's Days Inventory for the six months ended in . 20 is calculated as:

Days Inventory=Average Total Inventories (Q: . 20 )/Cost of Goods Sold (Q: . 20 )*Days in Period
=0/*365 / 2
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Implantica AG's Inventory Turnover for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Implantica AG Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Implantica AG's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Implantica AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines